Considering the strong impact that gal or VNPT55 have in promoting the degradation of AR/AR-Vs proteins, and thus, their preclinical anti-prostate cancer activities and their efficacy in the clinic (vide supra), another important focus in this study was also to determine whether these compounds induce apoptosis in PC cells. This evidence concerns the gene AR and prostate carcinoma.